|
|
Volumn 3, Issue 4, 1999, Pages 345-347
|
|
Pelvic radiation with concurrent chemotherapy compared with pelvi and para-aortic radiation for high-risk cervical cancer. Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. Cisplatin, radiation, and adjuvant hysterectomy for bulky stage Ib cervical carcinoma;Pelvic radiation with concurrent chemotherapy compared with pelvi and para-aortic radiation for high-risk cervical cancer. Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. Cisplatin, radiation, and adjuvant hysterectomy for bulky stage Ib cervical carcinoma]
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
BLEOMYCIN;
CISPLATIN;
FLUOROURACIL;
RADIOSENSITIZING AGENT;
VINCRISTINE;
ARTICLE;
BRACHYTHERAPY;
CANCER STAGING;
CLINICAL TRIAL;
COMPARATIVE STUDY;
CONTROLLED CLINICAL TRIAL;
FEMALE;
HUMAN;
HYSTERECTOMY;
LYMPH NODE METASTASIS;
MORTALITY;
MULTICENTER STUDY;
MULTIMODALITY CANCER THERAPY;
PATHOLOGY;
RANDOMIZED CONTROLLED TRIAL;
SURVIVAL;
TREATMENT OUTCOME;
UTERINE CERVIX TUMOR;
ANTINEOPLASTIC AGENTS;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
BLEOMYCIN;
BRACHYTHERAPY;
CISPLATIN;
COMBINED MODALITY THERAPY;
FEMALE;
FLUOROURACIL;
HUMANS;
HYSTERECTOMY;
LYMPHATIC METASTASIS;
MULTICENTER STUDIES;
NEOPLASM STAGING;
RADIATION-SENSITIZING AGENTS;
RANDOMIZED CONTROLLED TRIALS;
SURVIVAL ANALYSIS;
TREATMENT OUTCOME;
UTERINE CERVICAL NEOPLASMS;
VINCRISTINE;
MLCS;
MLOWN;
|
|
EID: 0033162538
PISSN: 12783218
EISSN: None
Source Type: Journal
DOI: 10.1016/s1278-3218(99)80082-1 Document Type: Article |
|
Times cited : (6)
|
|
References (0)
|
